LncRNA PCBP1-AS1 Induces Osteoporosis by Sponging MiR-126-5p/PAK2 Axis

Overview

Journal Bone Joint Res

Date 2023 Jun 12

PMID 37306572

Authors

Zhihui Li

Affiliations

Soon will be listed here.

Abstract

Aims: Long non-coding RNAs (lncRNAs) act as crucial regulators in osteoporosis (OP). Nonetheless, the effects and potential molecular mechanism of lncRNA PCBP1 Antisense RNA 1 (PCBP1-AS1) on OP remain largely unclear. The aim of this study was to explore the role of lncRNA PCBP1-AS1 in the pathogenesis of OP.

Methods: Using quantitative real-time polymerase chain reaction (qRT-PCR), osteogenesis-related genes (alkaline phosphatase (ALP), osteocalcin (OCN), osteopontin (OPN), and Runt-related transcription factor 2 (RUNX2)), PCBP1-AS1, microRNA (miR)-126-5p, group I Pak family member p21-activated kinase 2 (PAK2), and their relative expression levels were determined. Western blotting was used to examine the expression of PAK2 protein. Cell Counting Kit-8 (CCK-8) assay was used to measure cell proliferation. To examine the osteogenic differentiation, Alizarin red along with ALP staining was used. RNA immunoprecipitation assay and bioinformatics analysis, as well as a dual-luciferase reporter, were used to study the association between PCBP1-AS1, PAK2, and miR-126-5p.

Results: The expression of PCBP1-AS1 was pre-eminent in OP tissues and decreased throughout the development of human bone marrow-derived mesenchymal stem cells (hBMSCs) into osteoblasts. PCBP1-AS1 knockdown and overexpression respectively promoted and suppressed hBMSC proliferation and osteogenic differentiation capacity. Mechanistically, PCBP1-AS1 sponged miR-126-5p and consequently targeted PAK2. Inhibiting miR-126-5p significantly counteracted the beneficial effects of PCBP1-AS1 or PAK2 knockdown on hBMSCs' ability to differentiate into osteoblasts.

Conclusion: PCBP1-AS1 is responsible for the development of OP and promotes its progression by inducing PAK2 expression via competitively binding to miR-126-5p. PCBP1-AS1 may therefore be a new therapeutic target for OP patients.

Citing Articles

LINC01089 governs the miR-1287-5p/HSPA4 axis to negatively regulate osteogenic differentiation of mesenchymal stem cells.

Zou H, Hu F, Wu X, Xu B, Shang G, An D Bone Joint Res. 2024; 13(12):779-789.

PMID: 39679709 PMC: 11648573. DOI: 10.1302/2046-3758.1312.BJR-2023-0272.R2.

LINC01133 promotes the osteogenic differentiation of bone marrow mesenchymal stem cells by upregulating CTNNB1 by acting as a sponge for miR-214-3p.

Tang C, Huang L, Guo X, Wang G, Chen Z J Orthop Surg Res. 2024; 19(1):572.

PMID: 39285416 PMC: 11406849. DOI: 10.1186/s13018-024-05053-8.

Long noncoding RNA UNC5B-AS1 suppresses cell proliferation by sponging miR-24-3p in glioblastoma multiforme.

Song Y, Chen B, Jiao H, Yi L BMC Med Genomics. 2024; 17(1):83.

PMID: 38594690 PMC: 11003007. DOI: 10.1186/s12920-024-01851-5.

References

Tam C, Wong J, Tsui S, Zuo T, Chan T, Ng T . LncRNAs with miRNAs in regulation of gastric, liver, and colorectal cancers: updates in recent years. Appl Microbiol Biotechnol. 2019; 103(12):4649-4677. DOI: 10.1007/s00253-019-09837-5. View

Chen X, Ma F, Zhai N, Gao F, Cao G . Long non‑coding RNA XIST inhibits osteoblast differentiation and promotes osteoporosis via Nrf2 hyperactivation by targeting CUL3. Int J Mol Med. 2021; 48(1). PMC: 8175064. DOI: 10.3892/ijmm.2021.4970. View

Tong X, Gu P, Xu S, Lin X . Long non-coding RNA-DANCR in human circulating monocytes: a potential biomarker associated with postmenopausal osteoporosis. Biosci Biotechnol Biochem. 2015; 79(5):732-7. DOI: 10.1080/09168451.2014.998617. View

Yang Y, Yujiao W, Fang W, Linhui Y, Ziqi G, Zhichen W . The roles of miRNA, lncRNA and circRNA in the development of osteoporosis. Biol Res. 2020; 53(1):40. PMC: 7493179. DOI: 10.1186/s40659-020-00309-z. View

He Y, Chen Y . The potential role of lncRNAs in osteoporosis. J Bone Miner Metab. 2021; 39(3):341-352. DOI: 10.1007/s00774-021-01205-6. View

Oryan A, Sahvieh S . Effects of bisphosphonates on osteoporosis: Focus on zoledronate. Life Sci. 2020; 264:118681. DOI: 10.1016/j.lfs.2020.118681. View

Chen R, Qiu H, Tong Y, Liao F, Hu X, Qiu Y . MiRNA-19a-3p alleviates the progression of osteoporosis by targeting HDAC4 to promote the osteogenic differentiation of hMSCs. Biochem Biophys Res Commun. 2019; 516(3):666-672. DOI: 10.1016/j.bbrc.2019.06.083. View

Zhang B, Zhang M, Shen C, Liu G, Zhang F, Hou J . LncRNA PCBP1-AS1-mediated AR/AR-V7 deubiquitination enhances prostate cancer enzalutamide resistance. Cell Death Dis. 2021; 12(10):856. PMC: 8452729. DOI: 10.1038/s41419-021-04144-2. View

Queiroz A, Zhang B, Comstock D, Hao Y, Eriksson M, Hydbring P . miR-126-5p targets Malate Dehydrogenase 1 in non-small cell lung carcinomas. Biochem Biophys Res Commun. 2018; 499(2):314-320. DOI: 10.1016/j.bbrc.2018.03.154. View

10.

Li J, Liu S, Zhou H, Qu L, Yang J . starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2013; 42(Database issue):D92-7. PMC: 3964941. DOI: 10.1093/nar/gkt1248. View

11.

Rane C, Minden A . P21 activated kinases: structure, regulation, and functions. Small GTPases. 2014; 5. PMC: 4160339. DOI: 10.4161/sgtp.28003. View

12.

Sun Z, Ou C, Liu J, Chen C, Zhou Q, Yang S . YAP1-induced MALAT1 promotes epithelial-mesenchymal transition and angiogenesis by sponging miR-126-5p in colorectal cancer. Oncogene. 2018; 38(14):2627-2644. PMC: 6484768. DOI: 10.1038/s41388-018-0628-y. View

13.

Wu Z, Yin H, Liu T, Yan W, Li Z, Chen J . MiR-126-5p regulates osteoclast differentiation and bone resorption in giant cell tumor through inhibition of MMP-13. Biochem Biophys Res Commun. 2013; 443(3):944-9. DOI: 10.1016/j.bbrc.2013.12.075. View

14.

Miao Y, Lu J, Fan B, Sun L . MicroRNA-126-5p Inhibits the Migration of Breast Cancer Cells by Directly Targeting CNOT7. Technol Cancer Res Treat. 2020; 19:1533033820977545. PMC: 7711228. DOI: 10.1177/1533033820977545. View

15.

Wang B, Liu X . Long non-coding RNA KCNQ1OT1 promotes cell viability and migration as well as inhibiting degradation of CHON-001 cells by regulating miR-126-5p/TRPS1 axis. Adv Rheumatol. 2021; 61(1):31. DOI: 10.1186/s42358-021-00187-3. View

16.

Li Z, Pan C, Wang Z, Deng X, Zhu Q, Wu W . LncRNA PCBP1-AS1 correlated with the functional states of cancer cells and inhibited lung adenocarcinoma metastasis by suppressing the EMT progression. Carcinogenesis. 2021; 42(7):931-939. DOI: 10.1093/carcin/bgab047. View

17.

Rossi L, Copes R, Dal Osto L, Flores C, Comim F, Premaor M . Factors related with osteoporosis treatment in postmenopausal women. Medicine (Baltimore). 2018; 97(28):e11524. PMC: 6076108. DOI: 10.1097/MD.0000000000011524. View

18.

Curtis E, Moon R, Dennison E, Harvey N, Cooper C . Recent advances in the pathogenesis and treatment of osteoporosis. Clin Med (Lond). 2015; 15 Suppl 6:s92-6. PMC: 4876921. DOI: 10.7861/clinmedicine.15-6-s92. View

19.

Al-Hourani K, Tsang S, Simpson A . Osteoporosis: current screening methods, novel techniques, and preoperative assessment of bone mineral density. Bone Joint Res. 2021; 10(12):840-843. PMC: 8696546. DOI: 10.1302/2046-3758.1012.BJR-2021-0452.R1. View

20.

Tian L, Han F, Yang J, Ming X, Chen L . Long non‑coding RNA LINC01006 exhibits oncogenic properties in cervical cancer by functioning as a molecular sponge for microRNA‑28‑5p and increasing PAK2 expression. Int J Mol Med. 2021; 47(4). PMC: 7891833. DOI: 10.3892/ijmm.2021.4879. View